-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND won the First Prize of the 2009 China Federation of Commerce Science and Technology Award.
On December 26, 2009, the award ceremony for the “2009 China Federation of Commerce Science and Technology Award” was held at the Great Hall of the People. Our company’s independently developed project, “A Method and Production Process for Obtaining Highly Efficient Recombinant Protein Derivatives,” won the First Prize of the “2009 China Federation of Commerce Science and Technology Award.”
The “China Association of Commerce Science and Technology Award,” approved by the Ministry of Science and Technology, is established by the China Association of Commerce. It is the most authoritative and comprehensive award in China’s commercial sector for technological innovation. The results of the 2009 review have been published on the website of the National Office for Science and Technology Awards.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005